Stereotactic radiotherapy for oligoprogressive ER-positive breast cancer (AVATAR)

Overview of attention for article published in BMC Cancer, March 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

So far, Altmetric has seen 15 X posts from 15 X users, with an upper bound of 27,247 followers.

Stereotactic radiotherapy for oligoprogressive ER-positive breast cancer (AVATAR) #bcsm. https://t.co/AtIDQ9WZLs

Stereotactic radiotherapy for oligoprogressive ER-positive breast cancer (AVATAR) | BMC Cancer | Full Text https://t.co/ykPAgkqxlO

RT @drspdavid: We have now published our protocol for our ongoing trial AVATAR, investigating SABR in oligo-progressive, ER positive breast…

Answering important questions in oligometastatic ER+ breast cancer...will we redefine the paradigm?

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 11 additional X posts.